Explain in easy and understandable language focus more on individual drugs for medicinal chemistry exam
Reading File
Running Command
Running Command
Now I have all the content. Let me create a comprehensive, easy-to-understand drug-by-drug explanation for the medicinal chemistry exam.
💊 Drugs Acting on the Adrenergic (Sympathetic) System
Medicinal Chemistry Exam Notes — Drug-by-Drug Focus
Quick Background (30 seconds)
The adrenergic system uses three neurotransmitters: Norepinephrine (NE), Epinephrine (E), and Dopamine (DA). Drugs either mimic these (agonists/sympathomimetics) or block them (antagonists).
Receptors: α1, α2, β1, β2, β3 — each does something different.
🧬 SAR Quick Rules (Apply to ALL drugs below)
| Part of Molecule | What it does |
|---|---|
| meta + para -OH on ring | Direct adrenergic activity |
| No -OH on ring | Indirect acting only |
| Resorcinol instead of catechol | β2 selectivity + longer duration (resists COMT) |
| β-OH group | R-isomer = more potent (3-point attachment to receptor) |
| Small N-alkyl (CH₃) | α-activity, slows MAO |
| Large N-alkyl (t-butyl) | β2 selectivity, resists MAO |
| 2-carbon chain between ring and N | Optimal activity |
| α-methyl substitution | α2 selectivity + resists MAO |
PART 1 — ENDOGENOUS CATECHOLAMINES
1. 🔵 Dopamine (DA)
Class: Catecholamine | Action: Precursor of NE; direct β-receptor + D1 receptor agonist
| Feature | Detail |
|---|---|
| Receptors | D1 (low dose), β1 (moderate dose) |
| Route | IV only (no oral activity) |
| Duration | Short — metabolized by COMT + MAO rapidly |
| Use | Shock (increases cardiac output + renal blood flow) |
| Special | Does NOT raise BP significantly at low doses; increases urinary output via D1 action on kidneys |
Exam tip: DA → NE is made inside vesicles by dopamine-β-hydroxylase. At low doses = renal effect (D1); higher doses = heart effect (β1).
2. 🟠 Norepinephrine (NE / Noradrenaline)
Class: Catecholamine | Action: α1 + α2 + β1 + β3 agonist (NO β2 action)
| Feature | Detail |
|---|---|
| Receptors | α1, α2, β1, β3 |
| Route | IV only (polar, poor CNS penetration, poor oral absorption) |
| Duration | Very short (1–2 min) — rapidly metabolized by COMT + MAO |
| Use | Hypotensive crises, cardiac arrest (raises BP, stimulates heart) |
| Chirality | R-configuration is biologically active |
| Limitation | Non-selective → many side effects |
Exam tip: NE lacks β2 activity because it has no N-methyl group (compare with Epinephrine which has N-methyl and thus has β2 + β3 activity).
3. 🔴 Epinephrine (Adrenaline)
Class: Catecholamine | Action: Most potent — α1 + α2 + β1 + β2 + weak β3
| Feature | Detail |
|---|---|
| Receptors | All adrenergic receptors |
| Route | IV, inhalation, topical (NO oral — poor bioavailability) |
| Duration | Short (metabolized by COMT + MAO) |
| Uses | Cardiac arrest, anaphylaxis, asthma (inhalation), nasal congestion, open-angle glaucoma, prolongs local anesthesia, controls hemorrhage |
Prodrug: Dipivefrin = Epinephrine esterified with pivalic acid at both catechol -OH groups
- ↑ lipophilicity → better corneal penetration → used in glaucoma
- Converted back to Epinephrine in the eye
Exam tip: E has the N-methyl group → that's why it hits β2 (bronchodilation) and β3, while NE without N-methyl does NOT reach β2.
PART 2 — α1 AGONISTS
4. 🟡 Phenylephrine
Class: Phenylethanolamine | Action: Selective direct-acting α1-agonist
| Feature | Detail |
|---|---|
| Why α1 selective? | p-OH of catechol is REMOVED (para-OH removal = α1 selectivity per SAR) |
| Route | Oral + topical (active — longer DOA than E; ~twice the duration) |
| Potency | Less potent than E/NE but selective |
| Metabolism | O-glucuronidation/sulfation + MAO (NOT COMT, because no catechol) |
| Uses | Hypotension/shock, nasal decongestant (topical + oral), eye: mydriasis + glaucoma, prolongs spinal anesthesia |
Exam tip: Phenylephrine = epinephrine with the para-OH removed → loses β activity → becomes pure α1. This is a classic SAR question.
5. 🟡 Naphazoline, Oxymetazoline, Xylometazoline
Class: 2-Aralkylimidazolines | Action: α1-agonists (nasal/ophthalmic decongestants)
| Feature | Detail |
|---|---|
| Chemical class | Imidazoline ring fused with aryl group |
| pKa | 10–11 (very basic) → mostly ionized at physiological pH → limited CNS penetration |
| Ortho groups | Lipophilic ortho groups on phenyl ring = important for α-activity |
| Meta/para bulky groups | Important for α1-selectivity |
| Routes | Topical nasal + ophthalmic |
| Uses | Nasal decongestion, ophthalmic decongestant |
| Special warning | Oxymetazoline in large doses → CNS α2 action (like clonidine) → hypotension |
Exam tip: These drugs are ionized at body pH → can't cross BBB well → safe for topical use. But overdose of oxymetazoline = paradoxical hypotension (acts like clonidine centrally).
PART 3 — α2 AGONISTS
6. 🟢 Clonidine
Class: (Phenylimino)imidazolidine derivative | Action: Central α2-agonist + imidazoline receptor agonist
| Feature | Detail |
|---|---|
| Selectivity | Central α2 (reduces sympathetic outflow from brain) |
| Extra receptor | Imidazoline I1 receptor — contributes to BP lowering |
| Effects | ↓ BP, Bradycardia (vagus facilitation + cardiac prejunctional α2 stimulation) |
| Use | Hypertension |
| Mechanism | Centrally acts → ↓ NE release from brain → ↓ sympathetic tone → ↓ BP |
Exam tip: Clonidine is centrally acting — it's structurally an imidazolidine (not imidazoline like naphazoline). High affinity for imidazoline receptors distinguishes it.
7. 🟢 Methyldopa (α-Methyldopa)
Class: Amino acid analog | Action: Prodrug → active metabolite = α-methylnorepinephrine (selective α2-agonist)
| Feature | Detail |
|---|---|
| Route | Oral only (zwitterionic — poor solubility limits parenteral use) |
| Mechanism | Actively transported into CNS via aromatic amino acid transporter → decarboxylated by AADC → α-methyldopamine → stereospecifically hydroxylated → (1R,2S)-α-methylnorepinephrine |
| Why selective α2? | The (1R,2S) configuration of active metabolite = correct for α2 binding |
| Use | Hypertension (especially in pregnancy) |
| Parenteral form | Methyldopate (ester HCl salt) — more water soluble, converted back to methyldopa in body by esterases |
Exam tip: Methyldopa is a prodrug — it does nothing by itself. The active drug is α-methylnorepinephrine formed in the brain. The (1R,2S) stereochemistry is key for α2-selectivity.
PART 4 — DUAL α AND β (SELECTIVE β1)
8. 🔵 Dobutamine
Class: Catecholamine analog | Action: Racemic mixture with unique enantiomer properties
| Feature | Detail |
|---|---|
| Structure | Resembles DA but has a large 1-(methyl)-3-(4-hydroxyphenyl)propyl group on N |
| Racemate | (±) racemic mixture used clinically |
| S-(−) enantiomer | β1-agonist + α1-agonist (vasopressor) |
| R-(+) enantiomer | β1-agonist + α1-antagonist (vasodilator) |
| Net result | α effects CANCEL each other → acts like a selective β1-agonist |
| Route | IV only |
| Use | Congestive heart failure (↑ cardiac contractility without pressor effect) |
Exam tip: Dobutamine's brilliance is that its two enantiomers have opposite α-effects that cancel, leaving only β1 cardiac stimulation. This is a classic exam question about enantiomers.
PART 5 — β AGONISTS
9. 🔴 Isoprenaline (Isoproterenol / ISO)
Class: Catecholamine | Action: Non-selective β-agonist (β1 + β2 + β3, no α)
| Feature | Detail |
|---|---|
| Why no α activity? | Large N-isopropyl group → SAR rule: large N-substituent eliminates α activity |
| Route | Inhalation + injection (poor oral absorption) |
| Duration | Short (metabolized by COMT — sulfate/glucuronide conjugation) |
| Uses | Most potent bronchodilator (asthma), heart block treatment |
| Problem | Cardiac stimulation (β1) is a dangerous side effect when used for asthma |
Exam tip: ISO = prototype β-agonist. It has large N-isopropyl → no α, hits all β equally. Used as reference compound in SAR comparisons.
10. 🟡 Terbutaline
Class: Resorcinol bronchodilator | Action: Selective β2-agonist
| Feature | Detail |
|---|---|
| Ring modification | Resorcinol (3,5-diOH) instead of catechol (3,4-diOH) → β2 selectivity |
| Why longer DOA? | Resorcinol is NOT a COMT substrate → resistant to COMT metabolism |
| N-substituent | t-Butyl group → β2 selectivity (large bulky N-group per SAR) |
| Metabolism | Glucuronide conjugation (not MAO or COMT) |
| Routes | Oral (effective!) + inhalation |
| Use | Asthma, reversible bronchospasm |
Exam tip: Terbutaline has TWO features giving β2 selectivity — (1) resorcinol ring and (2) N-t-butyl group. These also make it orally active with longer duration.
11. 🟡 Salbutamol (Albuterol)
Class: Saligenin | Action: Selective β2-agonist
| Feature | Detail |
|---|---|
| Ring modification | meta-OH replaced with –CH₂OH (hydroxymethyl) group → β2 selectivity, resists COMT |
| Metabolism | Sulfate conjugation (not COMT, not MAO) |
| Routes | Oral + inhalation (orally active, longer DOA than ISO) |
| Use | Asthma |
| Stereochemistry issue | Racemate: S-(+) enantiomer enhances bronchial muscle contraction (undesirable!) |
| Pure R-form | Levalbuterol (Xopenex) = pure (R)-albuterol → same efficacy at 1/4 the dose, fewer side effects |
Exam tip: Salbutamol SAR — the –CH₂OH group at meta position is the key structural feature that confers β2 selectivity AND resistance to COMT. Levalbuterol is the pure active isomer.
12. 🟡 Bitolterol
Class: Catecholamine prodrug | Action: Prodrug of Colterol (β2-agonist)
| Feature | Detail |
|---|---|
| Prodrug mechanism | Both catechol –OH groups esterified with di-p-toluate esters |
| Why prodrug? | ↑ lipid solubility (lipophilic esters) → better lung deposition via inhalation |
| Activation | Esterases in lung cleave esters → active colterol released |
| Duration | 8 hours (prolonged due to slow release from ester prodrug) |
| Route | Inhalation only |
| Use | Bronchial asthma, reversible bronchospasm |
Exam tip: Bitolterol = prodrug strategy to prolong DOA. Esterification → increased lipophilicity → slow release → 8-hour action. Compare with Dipivefrin (same prodrug concept for Epinephrine in glaucoma).
PART 6 — INDIRECT-ACTING SYMPATHOMIMETICS
13. 🟤 Hydroxyamphetamine
Class: Phenylisopropylamine | Action: Indirect (releases NE from vesicles)
| Feature | Detail |
|---|---|
| Mechanism | Enters nerve ending via uptake-1 → displaces NE from storage granules |
| Use | Dilate pupil for diagnostic eye exams and eye surgery (mydriasis) |
14. 🟤 Propylhexedrine
Class: Cyclohexylamine (unusual) | Action: Indirect sympathomimetic
| Feature | Detail |
|---|---|
| Structural trick | Aromatic ring replaced with cyclohexane ring (to reduce CNS stimulation) |
| Effect | Vasoconstriction, nasal decongestant |
| Use | Relief of nasal congestion (cold, allergic rhinitis, sinusitis) |
15. 🟤 Pseudoephedrine
Class: Phenylethanolamine | Action: Mostly indirect acting
| Feature | Detail |
|---|---|
| Stereochemistry | (S,S) diastereoisomer of ephedrine |
| β-OH configuration | (S) configuration at β-carbon → wrong stereochemistry for direct receptor activation → mostly indirect |
| Source | Natural alkaloid from Ephedra species |
| Use | OTC nasal decongestant and cold medications |
Exam tip: Pseudoephedrine vs Ephedrine — same compound, different stereochemistry at β-OH. The (S) configuration at β-carbon eliminates direct activity → purely indirect agent.
PART 7 — MIXED MECHANISM (DIRECT + INDIRECT)
16. 🟠 Ephedrine
Class: Phenylethanolamine | Action: Mixed — direct α + β activity + indirect (releases NE)
| Feature | Detail |
|---|---|
| Lipophilicity | Less polar than catecholamines → crosses BBB → CNS stimulation (side effect) |
| Oral activity | Yes — longer DOA than Epinephrine |
| Use | CNS stimulant, bronchodilator (historically), decongestant |
| Compared to Pseudo | Ephedrine = (1R,2S) [erythro]; Pseudoephedrine = (1S,2S) [threo] |
17. 🟠 Metaraminol
Class: Phenylethanolamine | Action: Mainly direct α1 + some indirect
| Feature | Detail |
|---|---|
| Primary receptor | Direct α1 (vasoconstrictor) |
| Route | Parenteral (IV) |
| Use | Vasopressor in acute hypotension during spinal anesthesia |
🗂️ Master Summary Table
| Drug | Chemical Class | Receptor | Key Feature | Use |
|---|---|---|---|---|
| Dopamine | Catecholamine | D1, β1 | Precursor of NE | Shock |
| Norepinephrine | Catecholamine | α1, α2, β1 | No β2 (no N-methyl) | Hypotension, cardiac arrest |
| Epinephrine | Catecholamine | All α+β | N-methyl → β2 activity | Anaphylaxis, asthma, cardiac arrest |
| Dipivefrin | Prodrug of Epi | All α+β | Pivalate esters → ↑lipophilicity | Glaucoma |
| Phenylephrine | Phenylethanolamine | α1 selective | No p-OH → α1 only | Decongestant, hypotension |
| Naphazoline/Oxymetazoline | Imidazoline | α1 | Ionized at pH 7.4 → no CNS | Nasal decongestant |
| Clonidine | Imidazolidine | Central α2 | Imidazoline receptor too | Hypertension |
| Methyldopa | Amino acid prodrug | Central α2 | Prodrug → α-methyl-NE (1R,2S) | Hypertension |
| Dobutamine | Catecholamine | β1 (net) | Enantiomers cancel α-effects | Heart failure |
| Isoprenaline | Catecholamine | β1+β2+β3 | N-isopropyl → no α | Asthma, heart block |
| Terbutaline | Resorcinol | β2 selective | Resorcinol + t-butyl-N | Asthma |
| Salbutamol | Saligenin | β2 selective | –CH₂OH replaces meta-OH | Asthma |
| Levalbuterol | Saligenin (R-form) | β2 selective | Pure R-isomer, 1/4 dose | Asthma |
| Bitolterol | Catecholamine prodrug | β2 (as colterol) | Di-p-toluate ester → 8h DOA | Asthma |
| Ephedrine | Phenylethanolamine | α+β (mixed) | Crosses BBB, oral active | Decongestant, stimulant |
| Pseudoephedrine | Phenylethanolamine | Indirect | (S,S) config → no direct | OTC decongestant |
| Metaraminol | Phenylethanolamine | α1 (mainly) | Direct + some indirect | Spinal anesthesia hypotension |
| Hydroxyamphetamine | Phenylisopropylamine | Indirect | Releases NE | Mydriasis |
| Propylhexedrine | Cyclohexylamine | Indirect | Ring = cyclohexane (no CNS) | Nasal decongestant |
📌 Previous ESE Question Answers (from your PDF)
Q1: Mechanism of Action of Salbutamol (2M)
Salbutamol selectively activates β2-adrenergic receptors on bronchial smooth muscle → receptor couples to Gs protein → activates adenylyl cyclase → ↑ cAMP → activates PKA → phosphorylates myosin light chain kinase (MLCK) → relaxation of bronchial smooth muscle → bronchodilation.
It is resistant to COMT (due to –CH₂OH at meta position) and MAO (large N-t-butyl group), so it has prolonged action and oral activity.
Q2: Classify + Structure + Therapeutic Use of Terbutaline, Phenylephrine, Oxymetazoline, Clonidine (8M)
| Drug | Chemical Class | Receptor Selectivity | Therapeutic Use |
|---|---|---|---|
| Terbutaline | Resorcinol bronchodilator | Selective β2 | Asthma, reversible bronchospasm |
| Phenylephrine | Phenylethanolamine | Selective α1 | Nasal decongestion, hypotension, mydriasis |
| Oxymetazoline | 2-Aralkylimidazoline | α1 (topical); α2 (CNS overdose) | Nasal + ophthalmic decongestant |
| Clonidine | (Phenylimino)imidazolidine | Central α2 + imidazoline | Hypertension |
Good luck on your exam! Focus on: (1) Why each drug is selective (SAR features), (2) Prodrug mechanisms (Methyldopa, Bitolterol, Dipivefrin), (3) Stereochemistry (R vs S isomers, Dobutamine enantiomers), and (4) Metabolism differences (COMT vs MAO vs sulfate/glucuronide).
Can to give for ese pyq questions with exams
Running Command
Your PDF only has 2 ESE PYQs on page 79. I'll give you full exam-ready answers for both, plus predict likely future questions from the entire syllabus covered in your notes.
📝 ESE PYQ — Full Exam Answers
✅ Q1: Explain Mechanism of Action of Salbutamol (2 Marks)
Salbutamol (Albuterol) is a selective β2-adrenergic receptor agonist.
Mechanism:
- Salbutamol binds to β2-adrenergic receptors on bronchial smooth muscle cells
- β2 receptor is coupled to Gs protein → activates adenylyl cyclase enzyme
- Adenylyl cyclase converts ATP → cAMP (cyclic AMP — second messenger)
- ↑ cAMP activates Protein Kinase A (PKA)
- PKA phosphorylates Myosin Light Chain Kinase (MLCK) → inactivates it
- Result: Bronchial smooth muscle relaxes → Bronchodilation
Structural basis for selectivity:
- The –CH₂OH (hydroxymethyl) group at the meta position (replacing the meta-OH of catechol) → β2 selectivity + resistant to COMT
- Large N-t-butyl group → β2 selectivity + resistant to MAO
- Thus orally active with longer duration of action
✅ Q2: Classify, Draw Structure & Give Therapeutic Use of — Terbutaline, Phenylephrine, Oxymetazoline, Clonidine (8 Marks)
1. 🔵 TERBUTALINE
Chemical Class: Resorcinol bronchodilator (Phenylethanolamine with resorcinol ring)
Receptor Selectivity: Selective β2-agonist
Structure Key Points:
- Resorcinol ring (3,5-dihydroxy) instead of catechol (3,4-dihydroxy)
- N-t-butyl (tert-butyl) group on nitrogen
- β-OH on the side chain
OH OH
| |
HO-[3 5]-CH-CH₂-NH-C(CH₃)₃
|
OH (β-OH)
(Resorcinol ring + N-t-butyl)
Why β2 selective:
- Resorcinol ring → not a COMT substrate → longer DOA
- N-t-butyl group (large bulky group on N) → β2 selectivity per SAR rule
- Resistant to COMT + MAO → metabolized only by glucuronide conjugation
Therapeutic Use: Asthma, reversible bronchospasm (oral + inhalation)
2. 🟡 PHENYLEPHRINE
Chemical Class: Phenylethanolamine (Aminoalcohol)
Receptor Selectivity: Selective α1-agonist
Structure Key Points:
- Phenyl ring with only meta-OH (no para-OH — para-OH is REMOVED from epinephrine)
- N-methyl group (small substituent on N)
- β-OH on side chain
OH
|
HO-[3]-C₆H₄-CH(OH)-CH₂-NH-CH₃
(meta-OH only, no para-OH)
Why α1 selective:
- Removal of para-OH group from epinephrine → eliminates β activity → pure α1
- Small N-methyl → favors α-activity per SAR rule
- NOT a catechol → NOT metabolized by COMT → longer DOA than Epinephrine
Therapeutic Use:
- Nasal decongestant (oral + topical)
- Hypotension/shock
- Mydriasis (pupil dilation)
- Open-angle glaucoma
- Prolongs spinal anesthesia
3. 🟠 OXYMETAZOLINE
Chemical Class: 2-Aralkylimidazoline
Receptor Selectivity: α1-agonist (topical); CNS α2 in overdose
Structure Key Points:
- Imidazoline ring (5-membered ring with 2 nitrogens)
- Aryl group with ortho-lipophilic substituents (tert-butyl + methyl at ortho positions)
- Hydroxyl at para position of phenyl ring
(CH₃)₃C CH₃
\ /
[Phenyl ring with p-OH]
|
CH₂-[Imidazoline ring]
(2-aralkylimidazoline)
Key Properties:
- pKa = 10–11 → highly basic → mostly ionized at body pH → cannot cross BBB easily → safe topical use
- Ortho-lipophilic groups = important for α-activity
- Overdose → CNS penetration → α2 action → hypotension (clonidine-like effect)
Therapeutic Use: Topical nasal decongestant, ophthalmic decongestant
4. 🟢 CLONIDINE
Chemical Class: (Phenylimino)imidazolidine derivative
Receptor Selectivity: Central α2-agonist + Imidazoline I1 receptor agonist
Structure Key Points:
- Imidazolidine ring (saturated, unlike imidazoline)
- Dichlorophenyl group (2,6-dichloro substitution)
- Phenylimino bridge connecting the two rings
Cl Cl
\ /
[Phenyl ring]—N=[ Imidazolidine ring ]
(2,6-dichloro) (saturated 5-membered)
Mechanism:
- Acts centrally in the brain (CNS penetrant)
- Stimulates α2-receptors in brainstem → ↓ sympathetic outflow → ↓ BP
- Also stimulates imidazoline I1 receptors → further BP lowering
- Produces bradycardia by facilitating vagus nerve + stimulating cardiac prejunctional α2
Therapeutic Use: Hypertension (antihypertensive)
🔮 Predicted High-Probability Future ESE Questions
Based on all topics in your PDF, these are most likely to be asked:
| # | Predicted Question | Marks | Topic |
|---|---|---|---|
| 1 | Write SAR of sympathomimetic agents (phenylethanolamines) | 8–10M | SAR |
| 2 | Write a note on prodrugs in adrenergic agents (Dipivefrin, Bitolterol, Methyldopa) | 5M | Prodrugs |
| 3 | Explain how Methyldopa acts as a prodrug. What is its active metabolite? | 4M | Methyldopa |
| 4 | Explain the role of stereochemistry in adrenergic agents (Dobutamine / Salbutamol) | 4M | Stereochemistry |
| 5 | Classify sympathomimetic agents with examples | 4M | Classification |
| 6 | Explain biosynthesis and metabolism of catecholamines | 5M | Biochem |
| 7 | Write note on indirect-acting sympathomimetics | 4M | Indirect agents |
| 8 | Compare Epinephrine, Norepinephrine, Dopamine (receptor activity, uses) | 5M | Endogenous CAs |
| 9 | How does N-substitution affect receptor selectivity? (SAR amino group) | 4M | SAR |
| 10 | Write note on Dobutamine — why does the racemate act as β1-selective? | 4M | Dobutamine |
🎯 Top 5 "Sure Shot" Answers to Prepare
- SAR of sympathomimetics — Ring modifications + amino group + ethylene chain rules with examples
- Methyldopa mechanism — Prodrug → active metabolite → (1R,2S) config → α2 selective
- Dobutamine enantiomers — S = α1 agonist + β1; R = α1 antagonist + β1; Net = β1 only
- Bitolterol as prodrug — Ester → lipophilicity → prolonged 8h DOA
- Classification table — Direct/Indirect/Mixed + α1/α2/β1/β2 + chemical class for all drugs
This is a shared conversation. Sign in to Orris to start your own chat.